cmd condition onset (.xlsx)
Download original .xlsx file from GitHub
info
ResourceFile_cmd_condition_onset |
|
---|---|
0 |
Created by Britta Jewell on 25 March 2021 |
1 |
|
2 |
This file reads in parameters for the onset of each condition annually in the CMD module in the TLO model. Each tab represents one condition modelled. |
3 |
baseline_annual_probability has been calibrated for each condition to data from Malawi. All other parameters are from Professor Ed Gregg’s group. Where possible, sources are listed to the right of the parameter values. |
diabetes
parameter_name |
value |
Unnamed: 2 |
|
---|---|---|---|
0 |
baseline_annual_probability |
0.00028 |
|
1 |
rr_male |
1.15 |
Holden et al., 2013, UK Pop (CPRD) |
2 |
rr_0_4 |
0 |
Holden et al., 2013, UK Pop (CPRD) |
3 |
rr_5_9 |
0 |
Holden et al., 2013, UK Pop (CPRD) |
4 |
rr_10_14 |
0 |
Holden et al., 2013, UK Pop (CPRD) |
5 |
rr_15_19 |
0 |
Holden et al., 2013, UK Pop (CPRD) |
6 |
rr_20_24 |
1 |
Holden et al., 2013, UK Pop (CPRD) |
7 |
rr_25_29 |
1 |
Holden et al., 2013, UK Pop (CPRD) |
8 |
rr_30_34 |
1.6 |
Holden et al., 2013, UK Pop (CPRD) |
9 |
rr_35_39 |
2.215384615384615 |
Holden et al., 2013, UK Pop (CPRD) |
10 |
rr_40_44 |
3 |
Holden et al., 2013, UK Pop (CPRD) |
11 |
rr_45_49 |
4 |
Holden et al., 2013, UK Pop (CPRD) |
12 |
rr_50_54 |
4.5 |
Holden et al., 2013, UK Pop (CPRD) |
13 |
rr_55_59 |
6 |
Holden et al., 2013, UK Pop (CPRD) |
14 |
rr_60_64 |
6.5 |
Holden et al., 2013, UK Pop (CPRD) |
15 |
rr_65_69 |
7 |
Holden et al., 2013, UK Pop (CPRD) |
16 |
rr_70_74 |
4 |
Holden et al., 2013, UK Pop (CPRD) |
17 |
rr_75_79 |
3 |
Holden et al., 2013, UK Pop (CPRD) |
18 |
rr_80_84 |
2 |
Holden et al., 2013, UK Pop (CPRD) |
19 |
rr_85_89 |
2 |
Holden et al., 2013, UK Pop (CPRD) |
20 |
rr_90_94 |
1 |
Holden et al., 2013, UK Pop (CPRD) |
21 |
rr_95_99 |
1 |
Holden et al., 2013, UK Pop (CPRD) |
22 |
rr_100 |
1 |
Holden et al., 2013, UK Pop (CPRD) |
23 |
rr_urban |
||
24 |
rr_wealth_1 |
1 |
Bellou et al., Systematic Reviews, 2018 |
25 |
rr_wealth_2 |
0.8333333333333334 |
Bellou et al., Systematic Reviews, 2018 |
26 |
rr_wealth_3 |
0.7916666666666666 |
Bellou et al., Systematic Reviews, 2018 |
27 |
rr_wealth_4 |
0.75 |
Bellou et al., Systematic Reviews, 2018 |
28 |
rr_wealth_5 |
0.7083333333333334 |
Bellou et al., Systematic Reviews, 2018 |
29 |
rr_bmi_1 |
1.1 |
Bellou et al., Systematic Reviews, 2018 |
30 |
rr_bmi_2 |
1 |
Bellou et al., Systematic Reviews, 2018 |
31 |
rr_bmi_3 |
2.9 |
Bellou et al., Systematic Reviews, 2018 |
32 |
rr_bmi_4 |
6 |
Bellou et al., Systematic Reviews, 2018 |
33 |
rr_bmi_5 |
10 |
Bellou et al., Systematic Reviews, 2018 |
34 |
rr_low_exercise |
1.33 |
Bellou et al., Systematic Reviews, 2018 |
35 |
rr_high_salt |
1 |
|
36 |
rr_high_sugar |
1.2 |
Bellou et al., Systematic Reviews, 2018 |
37 |
rr_tobacco |
1.3 |
Bellou et al., Systematic Reviews, 2018 |
38 |
rr_alcohol |
||
39 |
rr_marital_status_1 |
||
40 |
rr_marital_status_2 |
||
41 |
rr_marital_status_3 |
||
42 |
rr_in_education |
1.2 |
Bellou et al., Systematic Reviews, 2018 |
43 |
rr_current_education_level_1 |
1.2 |
Bellou et al., Systematic Reviews, 2018 |
44 |
rr_current_education_level_2 |
1 |
Bellou et al., Systematic Reviews, 2018 |
45 |
rr_current_education_level_3 |
0.85 |
Bellou et al., Systematic Reviews, 2018 |
46 |
rr_unimproved_sanitation |
1 |
|
47 |
rr_no_access_handwashing |
1 |
|
48 |
rr_no_clean_drinking_water |
1.05 |
Estimates from Ed Gregg |
49 |
rr_wood_burning_stove |
1.05 |
Estimates from Ed Gregg |
50 |
rr_diabetes |
1 |
|
51 |
rr_hypertension |
1.75 |
Bellou et al., Systematic Reviews, 2018 |
52 |
rr_depression |
1.48 |
Bellou et al., Systematic Reviews, 2018 |
53 |
rr_chronic_kidney_disease |
1 |
|
54 |
rr_chronic_lower_back_pain |
1 |
|
55 |
rr_chronic_ischemic_heart_disease |
1 |
|
56 |
rr_cancers |
1 |
|
57 |
rr_hiv |
1 |
|
58 |
rr_ever_stroke |
1 |
|
59 |
rr_ever_heart_attack |
1 |
|
60 |
rr_diabetes_on_medication |
1 |
|
61 |
rr_hypertension_on_medication |
1 |
|
62 |
rr_chronic_kidney_disease_on_medication |
1 |
|
63 |
rr_chronic_lower_back_pain_on_medication |
1 |
|
64 |
rr_chronic_ischemic_heart_disease_on_medication |
1 |
|
65 |
rr_stroke_on_medication |
1 |
|
66 |
rr_heart_attack_on_medication |
1 |
hypertension
parameter_name |
value |
Unnamed: 2 |
|
---|---|---|---|
0 |
baseline_annual_probability |
0.0045 |
|
1 |
rr_male |
0.95 |
|
2 |
rr_0_4 |
0 |
Health Survey for England Hypertension Prevalence Models |
3 |
rr_5_9 |
0 |
Health Survey for England Hypertension Prevalence Models |
4 |
rr_10_14 |
0 |
Health Survey for England Hypertension Prevalence Models |
5 |
rr_15_19 |
0 |
Health Survey for England Hypertension Prevalence Models |
6 |
rr_20_24 |
0.33783783783783783 |
Health Survey for England Hypertension Prevalence Models |
7 |
rr_25_29 |
1.0033783783783785 |
Health Survey for England Hypertension Prevalence Models |
8 |
rr_30_34 |
1.0033783783783785 |
Health Survey for England Hypertension Prevalence Models |
9 |
rr_35_39 |
1 |
Health Survey for England Hypertension Prevalence Models |
10 |
rr_40_44 |
1 |
Health Survey for England Hypertension Prevalence Models |
11 |
rr_45_49 |
1.652027027027027 |
Health Survey for England Hypertension Prevalence Models |
12 |
rr_50_54 |
1.652027027027027 |
Health Survey for England Hypertension Prevalence Models |
13 |
rr_55_59 |
2.135135135135135 |
Health Survey for England Hypertension Prevalence Models |
14 |
rr_60_64 |
2.135135135135135 |
Health Survey for England Hypertension Prevalence Models |
15 |
rr_65_69 |
2.385135135135135 |
Health Survey for England Hypertension Prevalence Models |
16 |
rr_70_74 |
2.385135135135135 |
Health Survey for England Hypertension Prevalence Models |
17 |
rr_75_79 |
2.679054054054054 |
Health Survey for England Hypertension Prevalence Models |
18 |
rr_80_84 |
2.679054054054054 |
Health Survey for England Hypertension Prevalence Models |
19 |
rr_85_89 |
2.679054054054054 |
Health Survey for England Hypertension Prevalence Models |
20 |
rr_90_94 |
2.679054054054054 |
Health Survey for England Hypertension Prevalence Models |
21 |
rr_95_99 |
2.679054054054054 |
Health Survey for England Hypertension Prevalence Models |
22 |
rr_100 |
2.679054054054054 |
Health Survey for England Hypertension Prevalence Models |
23 |
rr_urban |
||
24 |
rr_wealth_1 |
1 |
Coyle et al., 2019, English GP Data |
25 |
rr_wealth_2 |
1.0396039603960396 |
Coyle et al., 2019, English GP Data |
26 |
rr_wealth_3 |
1.0693069306930694 |
Coyle et al., 2019, English GP Data |
27 |
rr_wealth_4 |
1.0396039603960396 |
Coyle et al., 2019, English GP Data |
28 |
rr_wealth_5 |
0.9900990099009901 |
Coyle et al., 2019, English GP Data |
29 |
rr_bmi_1 |
0.5263157894736842 |
Health Survey for England Hypertension Prevalence Models |
30 |
rr_bmi_2 |
1 |
Health Survey for England Hypertension Prevalence Models |
31 |
rr_bmi_3 |
1.6894736842105265 |
Health Survey for England Hypertension Prevalence Models |
32 |
rr_bmi_4 |
1.7210526315789474 |
Health Survey for England Hypertension Prevalence Models |
33 |
rr_bmi_5 |
2.2052631578947373 |
Health Survey for England Hypertension Prevalence Models |
34 |
rr_low_exercise |
1.16 |
Andriolo et al., 2019, EPIC-Potsdam Study |
35 |
rr_high_salt |
1.88 |
Chen et al., 2018, Taiwan, Genetic Study |
36 |
rr_high_sugar |
1.03 |
Estimate from Ed Greg |
37 |
rr_tobacco |
1.04 |
Andriolo et al., 2019, EPIC-Potsdam Study |
38 |
rr_alcohol |
1.31 |
Pajak et al., 2013, HAPIEE Study, Russia Poland Czech |
39 |
rr_marital_status_1 |
1 |
Estimate from Ed Greg |
40 |
rr_marital_status_2 |
1.449 |
Estimate from Ed Greg |
41 |
rr_marital_status_3 |
1.03 |
Estimate from Ed Greg |
42 |
rr_in_education |
1 |
|
43 |
rr_current_education_level_1 |
1.34 |
Health Survey for England Hypertension Prevalence Models |
44 |
rr_current_education_level_2 |
1 |
Health Survey for England Hypertension Prevalence Models |
45 |
rr_current_education_level_3 |
1.42 |
Health Survey for England Hypertension Prevalence Models |
46 |
rr_unimproved_sanitation |
1 |
|
47 |
rr_no_access_handwashing |
1 |
|
48 |
rr_no_clean_drinking_water |
1 |
|
49 |
rr_wood_burning_stove |
1 |
|
50 |
rr_diabetes |
1.92 |
Derakhshan et al., 2016, Iranian Study |
51 |
rr_hypertension |
1 |
|
52 |
rr_depression |
1.42 |
Lin et al., 2012, Meta-Analysis Depression and Hypertension |
53 |
rr_chronic_kidney_disease |
1 |
|
54 |
rr_chronic_lower_back_pain |
1 |
|
55 |
rr_chronic_ischemic_heart_disease |
1 |
|
56 |
rr_cancers |
1 |
|
57 |
rr_hiv |
1 |
|
58 |
rr_ever_stroke |
1 |
|
59 |
rr_ever_heart_attack |
1 |
|
60 |
rr_diabetes_on_medication |
1 |
|
61 |
rr_hypertension_on_medication |
1 |
|
62 |
rr_chronic_kidney_disease_on_medication |
1 |
|
63 |
rr_chronic_lower_back_pain_on_medication |
1 |
|
64 |
rr_chronic_ischemic_heart_disease_on_medication |
1 |
|
65 |
rr_stroke_on_medication |
1 |
|
66 |
rr_heart_attack_on_medication |
1 |
chronic_lower_back_pain
parameter_name |
value |
Unnamed: 2 |
|
---|---|---|---|
0 |
baseline_annual_probability |
0.006 |
|
1 |
rr_male |
1 |
|
2 |
rr_0_4 |
0 |
|
3 |
rr_5_9 |
0 |
|
4 |
rr_10_14 |
0 |
|
5 |
rr_15_19 |
0 |
|
6 |
rr_20_24 |
0.69 |
|
7 |
rr_25_29 |
1 |
|
8 |
rr_30_34 |
1.4461538461538461 |
|
9 |
rr_35_39 |
2.215384615384615 |
|
10 |
rr_40_44 |
2.769230769230769 |
|
11 |
rr_45_49 |
3.538461538461538 |
|
12 |
rr_50_54 |
3.815384615384615 |
|
13 |
rr_55_59 |
5 |
|
14 |
rr_60_64 |
4.923076923076923 |
|
15 |
rr_65_69 |
4.369230769230769 |
|
16 |
rr_70_74 |
4.369230769230769 |
|
17 |
rr_75_79 |
4.923076923076923 |
|
18 |
rr_80_84 |
4.369230769230769 |
|
19 |
rr_85_89 |
3.692307692307692 |
|
20 |
rr_90_94 |
1.6153846153846154 |
|
21 |
rr_95_99 |
1.5384615384615383 |
|
22 |
rr_100 |
1.5384615384615383 |
|
23 |
rr_urban |
||
24 |
rr_wealth_1 |
1 |
Docking et al, 2011; Cambridge City over 75s Cohort |
25 |
rr_wealth_2 |
0.9 |
Docking et al, 2011; Cambridge City over 75s Cohort |
26 |
rr_wealth_3 |
1 |
Docking et al, 2011; Cambridge City over 75s Cohort |
27 |
rr_wealth_4 |
1.4 |
Docking et al, 2011; Cambridge City over 75s Cohort |
28 |
rr_wealth_5 |
1.4 |
Docking et al, 2011; Cambridge City over 75s Cohort |
29 |
rr_bmi_1 |
1 |
Heuch et al., 2013, Follow-up in the Nord-Trøndelag Health Study |
30 |
rr_bmi_2 |
1 |
Heuch et al., 2013, Follow-up in the Nord-Trøndelag Health Study |
31 |
rr_bmi_3 |
1.21 |
Heuch et al., 2013, Follow-up in the Nord-Trøndelag Health Study |
32 |
rr_bmi_4 |
1.28 |
Heuch et al., 2013, Follow-up in the Nord-Trøndelag Health Study |
33 |
rr_bmi_5 |
1.28 |
Heuch et al., 2013, Follow-up in the Nord-Trøndelag Health Study |
34 |
rr_low_exercise |
||
35 |
rr_high_salt |
||
36 |
rr_high_sugar |
||
37 |
rr_tobacco |
1.78 |
Shiri et al., 2010; meta-analysis |
38 |
rr_alcohol |
||
39 |
rr_marital_status_1 |
1 |
Docking et al, 2011; Cambridge City over 75s Cohort |
40 |
rr_marital_status_2 |
1.4285714285714286 |
Docking et al, 2011; Cambridge City over 75s Cohort |
41 |
rr_marital_status_3 |
1.5714285714285716 |
Docking et al, 2011; Cambridge City over 75s Cohort |
42 |
rr_in_education |
1.5 |
Docking et al, 2011; Cambridge City over 75s Cohort |
43 |
rr_current_education_level_1 |
1.5 |
Docking et al, 2011; Cambridge City over 75s Cohort |
44 |
rr_current_education_level_2 |
1 |
Docking et al, 2011; Cambridge City over 75s Cohort |
45 |
rr_current_education_level_3 |
1 |
Docking et al, 2011; Cambridge City over 75s Cohort |
46 |
rr_unimproved_sanitation |
||
47 |
rr_no_access_handwashing |
||
48 |
rr_no_clean_drinking_water |
||
49 |
rr_wood_burning_stove |
||
50 |
rr_diabetes |
2.72 |
Pozzobbon et al, 2019, meta-analysis |
51 |
rr_hypertension |
0.79 |
Bae et al, 2015, KNHANES IV |
52 |
rr_depression |
1.5 |
Docking et al, 2011; Cambridge City over 75s Cohort |
53 |
rr_chronic_kidney_disease |
||
54 |
rr_chronic_lower_back_pain |
||
55 |
rr_chronic_ischemic_heart_disease |
||
56 |
rr_cancers |
||
57 |
rr_hiv |
1 |
|
58 |
rr_ever_stroke |
2.35 |
Wang et al, 2020 |
59 |
rr_ever_heart_attack |
1 |
|
60 |
rr_diabetes_on_medication |
1 |
|
61 |
rr_hypertension_on_medication |
1 |
|
62 |
rr_chronic_kidney_disease_on_medication |
1 |
|
63 |
rr_chronic_lower_back_pain_on_medication |
1 |
|
64 |
rr_chronic_ischemic_heart_disease_on_medication |
1 |
|
65 |
rr_stroke_on_medication |
1 |
|
66 |
rr_heart_attack_on_medication |
1 |
chronic_kidney_disease
parameter_name |
value |
Unnamed: 2 |
|
---|---|---|---|
0 |
baseline_annual_probability |
0.0007 |
|
1 |
rr_male |
1.25 |
Judge A. et al. Nep Dial Trans. 2012 |
2 |
rr_0_4 |
0 |
|
3 |
rr_5_9 |
0 |
|
4 |
rr_10_14 |
0 |
|
5 |
rr_15_19 |
0 |
|
6 |
rr_20_24 |
0.5154639175257733 |
Judge A. et al. Nep Dial Trans. 2012 |
7 |
rr_25_29 |
0.5154639175257733 |
Judge A. et al. Nep Dial Trans. 2012 |
8 |
rr_30_34 |
0.5154639175257733 |
Judge A. et al. Nep Dial Trans. 2012 |
9 |
rr_35_39 |
1 |
Judge A. et al. Nep Dial Trans. 2012 |
10 |
rr_40_44 |
1 |
Judge A. et al. Nep Dial Trans. 2012 |
11 |
rr_45_49 |
1.675257731958763 |
Judge A. et al. Nep Dial Trans. 2012 |
12 |
rr_50_54 |
1.675257731958763 |
Judge A. et al. Nep Dial Trans. 2012 |
13 |
rr_55_59 |
2.8762886597938144 |
Judge A. et al. Nep Dial Trans. 2012 |
14 |
rr_60_64 |
2.8762886597938144 |
Judge A. et al. Nep Dial Trans. 2012 |
15 |
rr_65_69 |
4.190721649484536 |
Judge A. et al. Nep Dial Trans. 2012 |
16 |
rr_70_74 |
4.190721649484536 |
Judge A. et al. Nep Dial Trans. 2012 |
17 |
rr_75_79 |
5.190721649484536 |
Judge A. et al. Nep Dial Trans. 2012 |
18 |
rr_80_84 |
5.190721649484536 |
Judge A. et al. Nep Dial Trans. 2012 |
19 |
rr_85_89 |
2.0876288659793816 |
Judge A. et al. Nep Dial Trans. 2012 |
20 |
rr_90_94 |
2.0876288659793816 |
Judge A. et al. Nep Dial Trans. 2012 |
21 |
rr_95_99 |
2.0876288659793816 |
Judge A. et al. Nep Dial Trans. 2012 |
22 |
rr_100 |
2.0876288659793816 |
Judge A. et al. Nep Dial Trans. 2012 |
23 |
rr_urban |
||
24 |
rr_wealth_1 |
1 |
Weldegiorgis M. et al. Nep Dial Trans. 2020 |
25 |
rr_wealth_2 |
1.26 |
Weldegiorgis M. et al. Nep Dial Trans. 2020 |
26 |
rr_wealth_3 |
1.36 |
Weldegiorgis M. et al. Nep Dial Trans. 2020 |
27 |
rr_wealth_4 |
1.63 |
Weldegiorgis M. et al. Nep Dial Trans. 2020 |
28 |
rr_wealth_5 |
1.73 |
Weldegiorgis M. et al. Nep Dial Trans. 2020 |
29 |
rr_bmi_1 |
1.02 |
Herrington WG. et al. PLoS One. 2017 |
30 |
rr_bmi_2 |
1 |
Herrington WG. et al. PLoS One. 2018 |
31 |
rr_bmi_3 |
1.45 |
Herrington WG. et al. PLoS One. 2019 |
32 |
rr_bmi_4 |
1.66 |
Herrington WG. et al. PLoS One. 2020 |
33 |
rr_bmi_5 |
2.2 |
Herrington WG. et al. PLoS One. 2021 |
34 |
rr_low_exercise |
||
35 |
rr_high_salt |
||
36 |
rr_high_sugar |
||
37 |
rr_tobacco |
1.24 |
Bello A et al. Clin J Am Soc Nephrol. 2008 |
38 |
rr_alcohol |
1.33 |
Hossain M et al. Nephron Clin Pract. 2012 |
39 |
rr_marital_status_1 |
1 |
Akrawi D et al. Eur J Intern Med. 2014 |
40 |
rr_marital_status_2 |
0.8620689655172414 |
Akrawi D et al. Eur J Intern Med. 2014 |
41 |
rr_marital_status_3 |
0.8620689655172414 |
Akrawi D et al. Eur J Intern Med. 2014 |
42 |
rr_in_education |
1.3454545454545452 |
Weldegiorgis M. et al. Nep Dial Trans. 2020 |
43 |
rr_current_education_level_1 |
1.1818181818181817 |
Fored C et al. Nep Dial Tran. 2003 |
44 |
rr_current_education_level_2 |
1 |
Fored C et al. Nep Dial Tran. 2003 |
45 |
rr_current_education_level_3 |
0.9090909090909091 |
Fored C et al. Nep Dial Tran. 2003 |
46 |
rr_unimproved_sanitation |
||
47 |
rr_no_access_handwashing |
||
48 |
rr_no_clean_drinking_water |
||
49 |
rr_wood_burning_stove |
||
50 |
rr_diabetes |
1.87 |
Bello A et al. Clin J Am Soc Nephrol. 2008 |
51 |
rr_hypertension |
1.75 |
Bello A et al. Clin J Am Soc Nephrol. 2008 |
52 |
rr_depression |
1.62 |
Kop W et al. Clin J Am Soc Nephrol. 2011 |
53 |
rr_chronic_kidney_disease |
1 |
|
54 |
rr_chronic_lower_back_pain |
1.3 |
Lipworth et al. PlosOne 2012 |
55 |
rr_chronic_ischemic_heart_disease |
1 |
|
56 |
rr_cancers |
1 |
|
57 |
rr_hiv |
1 |
|
58 |
rr_ever_stroke |
1 |
|
59 |
rr_ever_heart_attack |
1 |
|
60 |
rr_diabetes_on_medication |
1 |
|
61 |
rr_hypertension_on_medication |
1 |
|
62 |
rr_chronic_kidney_disease_on_medication |
1 |
|
63 |
rr_chronic_lower_back_pain_on_medication |
1 |
|
64 |
rr_chronic_ischemic_heart_disease_on_medication |
1 |
|
65 |
rr_stroke_on_medication |
1 |
|
66 |
rr_heart_attack_on_medication |
1 |
chronic_ischemic_hd
parameter_name |
value |
Unnamed: 2 |
|
---|---|---|---|
0 |
baseline_annual_probability |
8.6e-05 |
|
1 |
rr_male |
2.3 |
|
2 |
rr_0_4 |
0 |
|
3 |
rr_5_9 |
0 |
|
4 |
rr_10_14 |
0 |
|
5 |
rr_15_19 |
0 |
|
6 |
rr_20_24 |
0.1401360544217687 |
|
7 |
rr_25_29 |
1 |
|
8 |
rr_30_34 |
1 |
|
9 |
rr_35_39 |
1 |
|
10 |
rr_40_44 |
1 |
|
11 |
rr_45_49 |
1 |
|
12 |
rr_50_54 |
7 |
|
13 |
rr_55_59 |
7 |
|
14 |
rr_60_64 |
7 |
|
15 |
rr_65_69 |
7 |
|
16 |
rr_70_74 |
12 |
|
17 |
rr_75_79 |
12 |
|
18 |
rr_80_84 |
12 |
|
19 |
rr_85_89 |
12 |
|
20 |
rr_90_94 |
12 |
|
21 |
rr_95_99 |
12 |
|
22 |
rr_100 |
12 |
|
23 |
rr_urban |
||
24 |
rr_wealth_1 |
1 |
Witte et al., 2017, Deprivation Chronic Heart Failure, UK |
25 |
rr_wealth_2 |
1.12 |
Witte et al., 2017, Deprivation Chronic Heart Failure, UK |
26 |
rr_wealth_3 |
1.24 |
Witte et al., 2017, Deprivation Chronic Heart Failure, UK |
27 |
rr_wealth_4 |
1.36 |
Witte et al., 2017, Deprivation Chronic Heart Failure, UK |
28 |
rr_wealth_5 |
1.48 |
Witte et al., 2017, Deprivation Chronic Heart Failure, UK |
29 |
rr_bmi_1 |
1 |
Jousilahti et al, 1996, BMI CVD Finland |
30 |
rr_bmi_2 |
1 |
Jousilahti et al, 1996, BMI CVD Finland |
31 |
rr_bmi_3 |
2.08 |
Jousilahti et al, 1996, BMI CVD Finland |
32 |
rr_bmi_4 |
7.28 |
Jousilahti et al, 1996, BMI CVD Finland |
33 |
rr_bmi_5 |
12.48 |
Jousilahti et al, 1996, BMI CVD Finland |
34 |
rr_low_exercise |
2.4 |
Strazzullo et al, 2009, Meta-analysis |
35 |
rr_high_salt |
1.17 |
Strazzullo et al, 2009, Meta-analysis |
36 |
rr_high_sugar |
||
37 |
rr_tobacco |
1.4 |
Strazzullo et al, 2009, Meta-analysis |
38 |
rr_alcohol |
1.44 |
Emberson et al., 2005 Alcohol CHD |
39 |
rr_marital_status_1 |
||
40 |
rr_marital_status_2 |
||
41 |
rr_marital_status_3 |
||
42 |
rr_in_education |
1.67 |
Kilander et al, 2001, Swedish Cohort Men |
43 |
rr_current_education_level_1 |
1.67 |
Kilander et al, 2001, Swedish Cohort Men |
44 |
rr_current_education_level_2 |
1 |
|
45 |
rr_current_education_level_3 |
1 |
|
46 |
rr_unimproved_sanitation |
||
47 |
rr_no_access_handwashing |
||
48 |
rr_no_clean_drinking_water |
||
49 |
rr_wood_burning_stove |
||
50 |
rr_diabetes |
2.19 |
Asia Pacific Cohort Studies Collaboration, 2003 |
51 |
rr_hypertension |
3.8 |
Alderman et al, 1997, MI HTN |
52 |
rr_depression |
||
53 |
rr_chronic_kidney_disease |
1.55 |
Angelantonio et al., 2010, Prospective Study Iceland |
54 |
rr_chronic_lower_back_pain |
||
55 |
rr_chronic_ischemic_heart_disease |
||
56 |
rr_cancers |
||
57 |
rr_hiv |
1.61 |
|
58 |
rr_ever_stroke |
1 |
|
59 |
rr_ever_heart_attack |
1 |
|
60 |
rr_diabetes_on_medication |
1 |
|
61 |
rr_hypertension_on_medication |
0.72 |
Neal et al., Effects of ACE inhibitors, calcium antagonists, and other blood- pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration, The Lancet 2000 |
62 |
rr_chronic_kidney_disease_on_medication |
1 |
|
63 |
rr_chronic_lower_back_pain_on_medication |
1 |
|
64 |
rr_chronic_ischemic_heart_disease_on_medication |
1 |
|
65 |
rr_stroke_on_medication |
1 |
|
66 |
rr_heart_attack_on_medication |
1 |